7wireVentures January 8, 2025

Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment

Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’

Accolade shareholders to receive $7.03 per share in cash

San Francisco, CA and Seattle, WA January 8, 2025 – Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total equity value of approximately...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Insurance, Mergers & Acquisitions / JV, Provider, Self-insured, Technology, Trends
Related Articles:
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
Transcarent to acquire fellow health benefits navigator Accolade for $621M
Transcarent to acquire Accolade for $621 million
How Can Self-Insured Employers Identify Ways to Rein in Healthcare Costs?
MedCity Pivot: A Chat with Accolade’s Chief Health Officer

Share This Article